Usefulness of tests to measure platelet function

被引:14
作者
Breddin, HK
Harder, S
机构
[1] Int Inst Thrombosis & Vasc Dis eV, D-60598 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Inst Klin Pharmakol, D-6000 Frankfurt, Germany
来源
VASA-JOURNAL OF VASCULAR DISEASES | 2003年 / 32卷 / 03期
关键词
platelet function; thrombelastography; aggregation; diabetes mellitus;
D O I
10.1024/0301-1526.32.3.123
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Usefulness of tests to measure platelet function Platelet function tests are used to detect patients with abormal platelet function, which may be inborn or acquired or to detect increased platelet activation which may be accompanied by an increased risk of thrombosis. Platelet function tests are also used to monitor platelet function inhibitors as aspirin, clopidogrel or platelet membrane glycoprotein Iib/IIIa-inhibitors. Incorrect blood sampling is a major source of error in measuring platelet function. Global tests besides platelet count and bleeding time are thrombelastography, the platelet function analyzer (PFA) and possibly in the future the new Impact(R) -system. Specific tests measure platelet spreading and adhesion to defined surfaces. hi a series methods platelets are counted before and after passage of filter Some of these tests are partially standardized. a The most frequently measured platelet function is aggregation induced by ADP collagen or other substances as first described by Gustav Born. Some newer methods to perform aggregometry are described. Platelet activation can be detected by measuring spontaneous aggregation as ill the PAT-test. Prospective trials with this test have shown that enhanced spontaneous aggregation is a risk factor for new, vascular occlusions in diabetics and for myocardial infarctions in healthy individuals. The Wu and Hoak-test and the measurement of released platelet factor 4 or betaglobulin are of limited value. Flow cytometric methods are frequently used to measure platelet activation markers as CD 62 and others. Platelet induced thrombin generation is all interesting function to measure drug effects. None of the presently available platelet function tests is well standardized, so there is much room for improvement.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 47 条
  • [31] Characterization of an in vitro platelet function analyzer, PFA-100(TM)
    Kundu, SK
    Heilmann, EJ
    Sio, R
    Garcia, C
    Ostgaard, RA
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1996, 2 (04) : 241 - 249
  • [32] A comparison of the effects of aspirin on bleeding time measured using the Simplate(TM) method and closure time measured using the PFA-100(TM), in healthy volunteers
    Marshall, PW
    Williams, AJ
    Dixon, RM
    Growcott, JW
    Warburton, S
    Armstrong, J
    Moores, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (02) : 151 - 155
  • [33] Mascelli MA, 1997, CIRCULATION, V96, P3860
  • [34] STANDARDIZED NORMAL IVY BLEEDING TIME AND ITS PROLONGATION BY ASPIRIN
    MIELKE, CH
    KANESHIRO, MM
    MAHER, IA
    WEINER, JM
    RAPAPORT, SI
    [J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1969, 34 (02): : 204 - +
  • [35] Nowak G., 2001, Annals of Hematology, V80, pA49
  • [36] Osende JI, 2001, CIRCULATION, V103, P1488
  • [37] Schenk JF, 1996, HAEMOSTASIS, V26, P187
  • [38] SCHENK JF, 2001, THROMB HAEMOST S
  • [39] Schmitz G, 1998, THROMB HAEMOSTASIS, V79, P885
  • [40] Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: Role of platelet activation, fibrinogen and von Willebrand factor
    Shenkman, B
    Savion, N
    Dardik, R
    Tamarin, I
    Varon, D
    [J]. THROMBOSIS RESEARCH, 2000, 99 (04) : 353 - 361